Biotech Startup SomaGenics Looks to Directed SiRNA Libraries in Bid For a Piece of the Market | GenomeWeb

Looking to cash in on the market for RNAi libraries, a small biotech company called SomaGenics has begun developing siRNA libraries that are specifically designed to increase the ease with which scientists can select the most effective gene expression inhibitors.

“We focused on the need to make combinatorial libraries of inhibitors based on nucleic acids and select from those libraries therapeutic molecules that work best within the cell,” Brian Johnston, president, CEO, and founder of SomaGenics, told RNAi News.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.